Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 55-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

By Horacek Jiri Bubenikova-Valesova Vera Kopecek Milan Palenicek Tomas Dockery Colleen Mohr Pavel Höschl Cyril

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 389-409

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotic-Induced Weight Gain: Insights into Mechanisms of Action

By Roerig James L. Steffen Kristine J. Mitchell James E.

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 1035-1059

Adis International

Access to resources Recommend Favorite

Atypical antipsychotic drugs, diabetes and ethnicity

By Ananth Jambur Kolli Smitha Gunatilake Sarath Brown Steven

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1111-1124

Informa Healthcare

Access to resources Recommend Favorite

Atypical antipsychotic use in women with bipolar disorder appears to be associated with an increased risk of menstruation disorders

Reactions Weekly, Vol. 1, Iss. 1105, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Synthesis and Computational Studies on Aryloxypropyl Piperazine Derivatives as Potential Atypical Antipsychotic Agents

Letters in Drug Design & Discovery, Vol. 9, Iss. 2, 2012-02 ,pp. : 218-224

Bentham Science Publishers

Access to resources Recommend Favorite